Finance News – Drug Prices
What is your interest today?
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Pfizer and other drug companies make 'no commitments' to the White House on lower drug prices
Pfizer’s reluctance to guarantee reduced medication costs highlights ongoing challenges in achieving significant price cuts despite recent government efforts aimed at lowering expe...
Read Full Article →Trump is right about drug prices. He’s just going about it all wrong.
The current approach to addressing medication costs has not convinced investors, reflecting uncertainty about its impact on the pharmaceutical industry and overall market stability...
Read Full Article →Trump's push for lower drug prices is just asking Big Pharma to make less money
The executive order aimed at reducing medication costs led to a positive market reaction, as pharmaceutical companies saw their stock values increase despite potential impacts on t...
Read Full Article →Trump signs order aiming to cut some U.S. drug prices to match lower ones abroad
The executive action seeks to reduce prescription medication costs by aligning U.S. prices with those in other countries, potentially impacting pharmaceutical companies amid upcomi...
Read Full Article →Trump signs order aiming to slash US drug prices to match those abroad
The executive action introduces a pricing framework intended to reduce medication expenses in the US by aligning them with international rates, potentially impacting pharmaceutical...
Read Full Article →Eli Lilly stock sinks as pharma misses out on the market rally
Eli Lilly experienced a notable decline in share value as broader pharmaceutical stocks failed to benefit from the market’s upward movement, influenced by new government policies o...
Read Full Article →